Holen Sie sich die Stockscreener-App
42.61
3.62%
1.49
Schlusskurs vom Vortag:
$41.12
Offen:
$41.91
24-Stunden-Volumen:
1.39M
Relative Volume:
1.25
Marktkapitalisierung:
$1.23B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
9.5282
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+0.40%
1M Leistung:
+1.86%
6M Leistung:
-55.27%
1J Leistung:
-67.15%
1-Tages-Spanne:
$39.73
$42.73
1-Wochen-Bereich:
$39.73
$44.53
52-Wochen-Spanne:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
42.61 | 1.23B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical Systems Inc (INSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inspire Medical Systems Inc (INSP) Institutional Confidence - TradingKey
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems Inc (INSP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inspire Medical data highlights cardiovascular outcomes with neuromod for sleep apnea - MassDevice
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study - marketscreener.com
Inspire sleep apnea implant linked to fewer heart, stroke events - Stock Titan
Discipline and Rules-Based Execution in INSP Response - Stock Traders Daily
Oppenheimer reiterates Perform on Inspire Medical stock amid challenges By Investing.com - Investing.com Canada
Inspire Medical Systems, Inc. (INSP): Growth Potential and Investor Outlook in the Healthcare Sector - DirectorsTalk Interviews
Inspire Medical Systems Inc (INSP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
INSP Technical Analysis & Stock Price Forecast - Intellectia AI
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight - The Manila Times
Inspire Medical to discuss sleep apnea tech at Wells Fargo MedTech event - Stock Titan
Alphatec vs. Inspire Medical Systems: Investment Profiles in Medical DevicesNews and Statistics - IndexBox
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Healthcare Sector with a 26.65% Potential Upside - DirectorsTalk Interviews
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff - Seeking Alpha
Behavioral Patterns of INSP and Institutional Flows - Stock Traders Daily
Inspire Medical Systems Hits 52-Week Low at $39.29 Amidst Major Decline - Markets Mojo
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report? - Yahoo Finance
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now - Yahoo Finance
1 Profitable Stock Worth Your Attention and 2 We Find Risky - Yahoo Finance
Inspire Medical Systems stock hits 52-week low at 39.51 USD - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at 39.51 USD By Investing.com - Investing.com South Africa
Inspire Medical Deadline Reminder - TMX Newsfile
Mairs & Power Small Cap Fund's Inspire Medical Systems Inc(INSP) Holding History - GuruFocus
Can Inspire Medical Systems (INSP) Convert Revenue Beats Into Sustainable Earnings Strength? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside - DirectorsTalk Interviews
Cash Machine Trading Cheap – Inspire Medical Systems Stock Set to Run? - Trefis
Inspire Medical Systems Stock: Strong Cash Flow Poised for a Re-Rating? - Trefis
Inspire Medical Systems Inc (INSP) Shares Fall 4.0% -- What GF S - GuruFocus
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? - Insider Monkey
Soleus files 1.47M-share stake in Inspire Medical Systems (INSP) - Stock Titan
Analyst warns Inspire Medical has a problem lasting into 2028 - thestreet.com
Inspire Medical Systems (INSP) Cuts 2026 Outlook Amid Medicare Uncertainty and Insider Sale – What’s Changed? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a Potential 18.99% Upside in the Healthcare Sector - DirectorsTalk Interviews
A Look At Inspire Medical Systems (INSP) Valuation As Analyst Caution Rises On Reimbursement Coding Risks - Sahm
(INSP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inspire Medical drops as BofA cuts to underperform on lack of coding clarity - MSN
Here's why you should add Inspire Medical stock to your portfolio now - MSN
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39 - Moomoo
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
Inspire Medical Systems, Inc. Common Stock (NY: INSP - The Chronicle-Journal
BofA analysts downgrade Inspire Medical on reimbursement coding concerns - MassDevice
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):